CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Capmatinib

卡马替尼 杂质对照品Capmatinib Impurities

72 个杂质条目72 impurity entries

本页汇总 卡马替尼 的 72 个杂质对照品条目。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 72 impurity reference standards of Capmatinib. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 卡马替尼(Capmatinib)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesMechanism of capmatinib degradation in stress conditions including degradation product characterization using ultra-high-performance liquid chromatography-quadrupole-time of flight mass spectrometry and stability-indicating analytical method development
    Rapid communications in mass spectrometry : RCM · 2023 · Bhangare D et al.  ·  PMID 36226771  ·  DOI
  2. 分析方法Analytical MethodsLC-MS/MS method development and validation for novel targeted anticancer therapies adagrasib, capmatinib, ensartinib, entrectinib, larotrectinib, lorlatinib, pralsetinib, selpercatinib and sotorasib
    Journal of pharmaceutical and biomedical analysis · 2025 · Meertens M et al.  ·  PMID 40743983  ·  DOI
  3. 分析方法Analytical MethodsDevelopment and validation of an ultra-performance liquid chromatography-tandem mass spectrometry method to quantify the small molecule inhibitors adagrasib, alectinib, brigatinib, capmatinib, crizotinib, lorlatinib, selpercatinib, and sotorasib in human plasma
    Biomedical chromatography : BMC · 2024 · Hollander EM et al.  ·  PMID 39136165  ·  DOI
  4. 分析方法Analytical MethodsDevelopment and full validation of an LC-MS/MS methodology to quantify capmatinib (INC280) following intragastric administration to rats
    Biomedical chromatography : BMC · 2020 · Fan X et al.  ·  PMID 31821576  ·  DOI
  5. 分析方法Analytical MethodsQuantitation of capmatinib, a mesenchymal-epithelial transition factor inhibitor by UPLC-MS/MS in rat plasma and its application to a pharmacokinetic study
    Bioanalysis · 2020 · Zhou C et al.  ·  PMID 32186402  ·  DOI

卡马替尼 —— 原料药与杂质对照品Capmatinib — drug substance & impurities

共 73 个条目(含原料药本体)73 items incl. the drug substance
Capmatinib structure
原料药 APIAPI
卡马替尼Capmatinib
Capmatinib
CAS No.1029712-80-8
Chemical FormulaC23H17FN6O
Purity>95%询价On request
10mg25mg50mg100mg
Capmatinib Impurity 1 structure
1
卡马替尼杂质1Capmatinib Impurity 1
Capmatinib Impurity 1
CAS No.1029713-99-2
Chemical FormulaC22H15FN6O
Purity>95%询价On request
10mg25mg50mg100mg
3
卡马替尼杂质3Capmatinib Impurity 3
Capmatinib Impurity 3
CAS No.1029714-32-6
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
4
卡马替尼杂质4Capmatinib Impurity 4
Capmatinib Impurity 4
CAS No.2527512-55-4
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
5
卡马替尼杂质5Capmatinib Impurity 5
Capmatinib Impurity 5
CAS No.3026867-45-5
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
6
卡马替尼杂质6Capmatinib Impurity 6
Capmatinib Impurity 6
CAS No.2570947-98-5
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
7
卡马替尼杂质7Capmatinib Impurity 7
Capmatinib Impurity 7
CAS No.2570947-90-7
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
8
卡马替尼杂质8Capmatinib Impurity 8
Capmatinib Impurity 8
CAS No.1029714-15-5
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
9
卡马替尼杂质9Capmatinib Impurity 9
Capmatinib Impurity 9
CAS No.1029713-75-4
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
10
卡马替尼杂质10Capmatinib Impurity 10
Capmatinib Impurity 10
CAS No.1635406-90-4
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
11
卡马替尼杂质11Capmatinib Impurity 11
Capmatinib Impurity 11
CAS No.1332952-19-8
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
12
卡马替尼杂质12Capmatinib Impurity 12
Capmatinib Impurity 12
CAS No.1332952-11-0
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
13
卡马替尼杂质13Capmatinib Impurity 13
Capmatinib Impurity 13
CAS No.1029714-18-8
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
14
卡马替尼杂质14Capmatinib Impurity 14
Capmatinib Impurity 14
CAS No.1029713-95-8
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
15
卡马替尼杂质15Capmatinib Impurity 15
Capmatinib Impurity 15
CAS No.1029714-25-7
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
16
卡马替尼杂质16Capmatinib Impurity 16
Capmatinib Impurity 16
CAS No.1029714-24-6
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
17
卡马替尼杂质17Capmatinib Impurity 17
Capmatinib Impurity 17
CAS No.1029714-33-7
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
18
卡马替尼杂质18Capmatinib Impurity 18
Capmatinib Impurity 18
CAS No.1029714-28-0
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
19
卡马替尼杂质19Capmatinib Impurity 19
Capmatinib Impurity 19
CAS No.1029714-27-9
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
20
卡马替尼杂质20Capmatinib Impurity 20
Capmatinib Impurity 20
CAS No.1029714-23-5
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
21
卡马替尼杂质21Capmatinib Impurity 21
Capmatinib Impurity 21
CAS No.1029714-20-2
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
22
卡马替尼杂质22Capmatinib Impurity 22
Capmatinib Impurity 22
CAS No.3026868-59-4
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
23
卡马替尼杂质23Capmatinib Impurity 23
Capmatinib Impurity 23
CAS No.3056647-55-0
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
24
卡马替尼杂质24Capmatinib Impurity 24
Capmatinib Impurity 24
CAS No.1029714-29-1
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
25
卡马替尼杂质25Capmatinib Impurity 25
Capmatinib Impurity 25
CAS No.1029714-26-8
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
26
卡马替尼杂质26Capmatinib Impurity 26
Capmatinib Impurity 26
CAS No.3056647-58-3
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
27
卡马替尼杂质27Capmatinib Impurity 27
Capmatinib Impurity 27
CAS No.1029714-07-5
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
28
卡马替尼杂质28Capmatinib Impurity 28
Capmatinib Impurity 28
CAS No.1029714-19-9
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
29
卡马替尼杂质29Capmatinib Impurity 29
Capmatinib Impurity 29
CAS No.1029714-03-1
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
30
卡马替尼杂质30Capmatinib Impurity 30
Capmatinib Impurity 30
CAS No.1029713-97-0
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
31
卡马替尼杂质31Capmatinib Impurity 31
Capmatinib Impurity 31
CAS No.1029714-14-4
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
32
卡马替尼杂质32Capmatinib Impurity 32
Capmatinib Impurity 32
CAS No.1029713-74-3
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
33
卡马替尼杂质33Capmatinib Impurity 33
Capmatinib Impurity 33
CAS No.1029716-34-4
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
34
卡马替尼杂质34Capmatinib Impurity 34
Capmatinib Impurity 34
CAS No.1029714-22-4
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
35
卡马替尼杂质35Capmatinib Impurity 35
Capmatinib Impurity 35
CAS No.1029714-21-3
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
36
卡马替尼杂质36Capmatinib Impurity 36
Capmatinib Impurity 36
CAS No.1029714-00-8
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
37
卡马替尼杂质37Capmatinib Impurity 37
Capmatinib Impurity 37
CAS No.3056647-13-0
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
38
卡马替尼杂质38Capmatinib Impurity 38
Capmatinib Impurity 38
CAS No.1029714-74-6
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
39
卡马替尼杂质39Capmatinib Impurity 39
Capmatinib Impurity 39
CAS No.1029714-31-5
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
40
卡马替尼杂质40Capmatinib Impurity 40
Capmatinib Impurity 40
CAS No.3026868-57-2
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
41
卡马替尼杂质41Capmatinib Impurity 41
Capmatinib Impurity 41
CAS No.1029714-08-6
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
42
卡马替尼杂质42Capmatinib Impurity 42
Capmatinib Impurity 42
CAS No.1029714-06-4
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
43
卡马替尼杂质43Capmatinib Impurity 43
Capmatinib Impurity 43
CAS No.1029714-30-4
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
44
卡马替尼杂质44Capmatinib Impurity 44
Capmatinib Impurity 44
CAS No.1029713-96-9
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
45
卡马替尼杂质45Capmatinib Impurity 45
Capmatinib Impurity 45
CAS No.3026868-58-3
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
46
卡马替尼杂质46Capmatinib Impurity 46
Capmatinib Impurity 46
CAS No.1029713-73-2
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
47
卡马替尼杂质47Capmatinib Impurity 47
Capmatinib Impurity 47
CAS No.1029714-34-8
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
48
卡马替尼杂质48Capmatinib Impurity 48
Capmatinib Impurity 48
CAS No.1029714-16-6
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
49
卡马替尼杂质49Capmatinib Impurity 49
Capmatinib Impurity 49
CAS No.1029716-33-3
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
50
卡马替尼杂质50Capmatinib Impurity 50
Capmatinib Impurity 50
CAS No.1348321-57-2
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
51
卡马替尼杂质51Capmatinib Impurity 51
Capmatinib Impurity 51
CAS No.2650080-02-5
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
52
卡马替尼杂质52Capmatinib Impurity 52
Capmatinib Impurity 52
CAS No.1332951-80-0
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
53
卡马替尼杂质53Capmatinib Impurity 53
Capmatinib Impurity 53
CAS No.1029713-44-7
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
54
卡马替尼杂质54Capmatinib Impurity 54
Capmatinib Impurity 54
CAS No.1869949-03-0
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
55
卡马替尼杂质55Capmatinib Impurity 55
Capmatinib Impurity 55
CAS No.1332951-88-8
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
56
卡马替尼杂质56Capmatinib Impurity 56
Capmatinib Impurity 56
CAS No.1185764-41-3
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
57
卡马替尼杂质57Capmatinib Impurity 57
Capmatinib Impurity 57
CAS No.2649974-28-5
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
58
卡马替尼杂质58Capmatinib Impurity 58
Capmatinib Impurity 58
CAS No.3003798-45-3
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
59
卡马替尼杂质59Capmatinib Impurity 59
Capmatinib Impurity 59
CAS No.3003798-65-7
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
Capmatinib Impurity 60 structure
60
卡马替尼杂质60Capmatinib Impurity 60
Capmatinib Impurity 60
CAS No.1029714-88-2
Chemical FormulaC22H14FN5O2
Purity>95%询价On request
10mg25mg50mg100mg
61
卡马替尼杂质61Capmatinib Impurity 61
Capmatinib Impurity 61
CAS No.1029713-77-6
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
62
卡马替尼杂质62Capmatinib Impurity 62
Capmatinib Impurity 62
CAS No.3003798-70-4
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
63
卡马替尼杂质63Capmatinib Impurity 63
Capmatinib Impurity 63
CAS No.1185764-42-4
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
64
卡马替尼杂质64Capmatinib Impurity 64
Capmatinib Impurity 64
CAS No.3003798-49-7
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
65
卡马替尼杂质65Capmatinib Impurity 65
Capmatinib Impurity 65
CAS No.3048497-59-9
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
66
卡马替尼杂质66Capmatinib Impurity 66
Capmatinib Impurity 66
CAS No.3003798-67-9
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
67
卡马替尼杂质67Capmatinib Impurity 67
Capmatinib Impurity 67
CAS No.1029716-71-9
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
68
卡马替尼杂质68Capmatinib Impurity 68
Capmatinib Impurity 68
CAS No.3003798-52-2
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
69
卡马替尼杂质69Capmatinib Impurity 69
Capmatinib Impurity 69
CAS No.1022088-22-7
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
70
卡马替尼杂质70Capmatinib Impurity 70
Capmatinib Impurity 70
CAS No.2876917-27-8
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
71
卡马替尼杂质71Capmatinib Impurity 71
Capmatinib Impurity 71
CAS No.3003798-68-0
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
72
卡马替尼杂质72Capmatinib Impurity 72
Capmatinib Impurity 72
CAS No.3003798-59-9
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
73
卡马替尼杂质73Capmatinib Impurity 73
Capmatinib Impurity 73
CAS No.3003798-57-7
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

卡马替尼 —— 研究文献与合成路线Capmatinib — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 卡马替尼 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Capmatinib. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. Mechanism of capmatinib degradation in stress conditions including degradation product characterization using ultra-high-performance liquid chromatography-quadrupole-time of flight mass spectrometry and stability-indicating analytical method development
    Bhangare D, Rajput N, Jadav T, et al. · Rapid communications in mass spectrometry : RCM · 2023 · 被引 2cited 2

合成路线文献Synthetic-route papers

  1. Perfluoro-tert-butyl Group-Derived Capmatinib: Synthesis, Biological Evaluation and Its Application in 19 F Magnetic Resonance Imaging
    Zhang X, Wang L, Huang R, et al. · Chembiochem : a European journal of chemical biology · 2023

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

卡马替尼 杂质谱研究要点Capmatinib — impurity profiling notes

下面这些是拿到 卡马替尼 的 73 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 73 impurity entries for Capmatinib, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances